𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of dopamine, D-1 and D-2 dopaminergic agonists on the excitability of hippocampal CA1pyramidal cells in guinea pig

✍ Scribed by N. Berretta; F. Berton; R. Bianchi; M. Capogna; W. Francesconi; M. Brunelli


Publisher
Springer-Verlag
Year
1990
Tongue
English
Weight
665 KB
Volume
83
Category
Article
ISSN
0014-4819

No coin nor oath required. For personal study only.

✦ Synopsis


In hippocampal pyramidal cells (HPCs), Dopamine (DA) application (1 microM) produced, in 50% of recorded cells, an hyperpolarization of the resting membrane potential (r.m.p.) and an increase of the afterhyperpolarization (AHP) amplitude and duration in 79% of recorded cells. DA-induced effects on both the r.m.p. and AHP were mimicked by bath application of a D-1 selective agonist, SKF 38393 (20 microM). In addition, we have observed that a D-1 selective antagonist such as SCH 23390 (1 microM) abolished the action of both DA and SKF 38393. In contrast, the activation of D-2 receptors through LY 171555 (10 microns) produced, in 50% of cells, a depolarization of the r.m.p. and a depression of the AHP in 67% of recorded cells. These results suggest that the effects observed in hippocampal pyramidal neurons after DA application of micromolar concentration are mediated by D-1 subtype of receptors.


πŸ“œ SIMILAR VOLUMES


Role of dopamine D-1 and D-2 receptor su
✍ M. T. Martin-Iverson; C. T. Dourish πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 556 KB

The effects of selective D-2 and D-1 dopamine (DA) receptor agonists on food consumption were investigated in free-feeding rats. A selective D-2 receptor agonist, (+)-4-propyl-9-hydroxynaphthoxazine (PHNO), increased the consumption of standard food pellets in the dose range of 7.5-120 micrograms/kg

Effect of the putative dopamine D1 agoni
✍ L. Verhagen Metman; P. J. Blanchet; D. de Jong; M. M. Mouradian; Dr. T. N. Chase πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 433 KB

## Abstract The ergoline derivative FCE 23884 acts as a dopamine D~1~ agonist in untreated parkinsonian animals and as a D~2~ antagonist in animals whose dopamine system is intact or levodopa treated. To evaluate whether this dual action might benefit patients with Parkinson's disease (PD) who have

Biphasic effects of dopamine D-2 recepto
✍ Jaime M. Monti; Marjorie Hawkins; HΓ©ctor Jantos; Luisa D'Angelo; MΓ³nica FernΓ‘nde πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 670 KB

The effects of the dopamine (DA) receptor agonists apomorphine, bromocriptine and pergolide were compared with those produced by a DA receptor antagonist, haloperidol, in rats implanted with electrodes for chronic sleep recordings. Apomorphine (0.025-2.0 mg/kg) and bromocriptine (0.25-6.0 mg/kg) ind